Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people globally. The company is headquartered in New York, New York.
| Revenue (TTM) | $27.95B |
| Gross Profit (TTM) | $12.29B |
| EBITDA | $7.76B |
| Operating Margin | 26.30% |
| Return on Equity | 25.90% |
| Return on Assets | 7.24% |
| Revenue/Share (TTM) | $57.50 |
| Book Value | $31.77 |
| Price-to-Book | 5.92 |
| Price-to-Sales (TTM) | 3.17 |
| EV/Revenue | 3.958 |
| EV/EBITDA | 15.33 |
| Quarterly Earnings Growth (YoY) | 7.30% |
| Quarterly Revenue Growth (YoY) | 6.20% |
| Shares Outstanding | $477.21M |
| Float | $476.27M |
| % Insiders | 0.08% |
| % Institutions | 94.13% |
Volatility is currently contracting
Rising employer healthcare costs could boost Marsh's consulting demand and create growth avenues for UnitedHealth and Centene through cost-control solutions.
MRSH sees moderate 2027 U.S. pay hikes as AI reshapes compensation planning and Cyber Protect expands its risk services across Asia.
SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Marsh and Resilience today announced the launch of Cyber Protect in Asia.
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a leading global professional services firm, today released the results of its July 2026 Mercer QuickPulse® US Compensation Planning Survey. Mercer, a people and investments leader, is transitioning to the Marsh brand in September. The survey of 1,001 U.S. organizations found that employers on average plan to set base salary merit increases at 3.2% and total salary increases at 3.5% in 2027—including merit, promotions, cost-of-living, and other adj.
Marsh (MRSH) reported earnings 30 days ago. What's next for the stock?
MRSH's MMA is set to acquire Accel, expanding its Midwest reach and adding agribusiness, benefits, wealth and retirement capabilities.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Marsh & McLennan Companies, Inc. remains a compelling long-term growth play despite recent underperformance and cyclical headwinds in the insurance sector. Q2 2026 saw resilient 6% revenue growth, driven mainly by organic initiatives, but margin pressure from rising expenses and a soft P&C pricing cycle. MRSH stock's valuation at 20x forward earnings is below its five-year average, supporting a maintained 'buy' rating as cyclical weakness overshadows solid fundamentals.
MRSH beats Q2 earnings estimates as Consulting and Risk & Insurance Services fuel revenue growth despite higher operating expenses.
Marsh & McLennan Companies, Inc. (MRSH) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MRSH and any ticker you trade — then tracks every position and per-strategy win rate.
